Journals Library

HTA - 08/116/12

Amisulpride augmentation in clozapine-unresponsive schizophrenia AMICUS

Project title: Amisulpride augmentation in clozapine-unresponsive schizophrenia AMICUS

Call to action: 08/116 08/116 HTA Clinical Trials - April 2009 Board submissions (Oct 08 deadline)

Research type: Primary Research

Chief investigator: Professor Thomas BarnesORCID

Lead Author: Professor Thomas BarnesORCID

Contractor: Imperial College London

Cost: £1,148,900.00

Co-investigators: Dr Andrew Procter, Dr Carol Paton, Dr Louise Marston, Professor David Osborn, Professor Linda Davies, Professor Michael King, Professor Peter Haddad.

Started: April 2011 | Status: Published September 2017

ISRCTN: 68824876

This trial of adding amisulpride in clozapine-unresponsive schizophrenia under-recruited and did not show any statistically significant response at 12 weeks.

Links to project documentation

The links and documents below are related to this research and are added as and when they are produced over the life of the project. The information is provided by the researchers and some may have undergone varying editorial, production and publication models, which differ to NIHR Journals Library reports. Links are to both internal (NIHR) and external websites – the NIHR is not responsible for the content of external websites.

Background & Research Questions

Why the research is being done and what is being asked


How the research is being done

Publications & Outputs

What the research produced

Outcomes & Impact

What happened as a result of the research

If you would like to receive a notification when this project is updated, please submit your email address below. This will also notify you when the Journals Library report is published.